Long-term, Open-label Study of SAR447537 (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency Emphysema

Clinical trial NCT05897424 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05897424
Sponsor: Sanofi
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Alpha 1-Antitrypsin Deficiency Emphysema

Start date: 2024-06-20
Primary completion: 2028-06-30
Enrollment: 185

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.